Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer

Neuroendocrine prostate cancer (NEPC) is a highly aggressive subtype of prostate cancer (PC) that commonly emerges through a transdifferentiation process from prostate adenocarcinoma and evades conventional therapies. Extensive molecular research has revealed factors that drive lineage plasticity, u...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamora, Irene, Freeman, Michael R., Encío, Ignacio J., Rotinen, Mirja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531052/
https://www.ncbi.nlm.nih.gov/pubmed/37761978
http://dx.doi.org/10.3390/ijms241813673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531052/
https://www.ncbi.nlm.nih.gov/pubmed/37761978
http://dx.doi.org/10.3390/ijms241813673

Ejemplares similares